Thank you for supporting epiliquid.
Depending on when you invested, there may not have been a simple way to measure our progress: experiments that would take months to produce useful results, agreements still being negotiated, and decisions whose value would only become clear later. Some of that has changed. But progress at epiliquid is still measured mostly in data, protocols, agreements, and decisions, not in revenue. That is why this page exists.
I built it because I want you to hear from me regularly, not only when I need something. Each month, I will explain what happened: which programs moved forward, which assumptions changed, what took longer than expected, how we used the cash, and which decisions are ahead. Some months will include clear milestones. Others will be mostly lab work, clinical coordination, or a problem we are still working through. I will report both with the same level of clarity.
I do not expect you to follow every technical detail. I do want you to have a clear view of the company you backed.
Write to me whenever you have a question, disagree with a decision, or think there is someone we should meet. I read and answer all these messages myself.
To request access for another member of your team, or if you have any questions about a report, write to investors@epiliquid.com. Access is granted per named email address, so forwarding this link will not give someone else entry.